المؤلفون: Johnson-Ansah, Hyacinthe¹ (AUTHOR), Maneglier, Benjamin² (AUTHOR), Huguet, Françoise³ (AUTHOR), Legros, Laurence⁴ (AUTHOR), Escoffre-Barbe, Martine⁵ (AUTHOR), Gardembas, Martine⁶ (AUTHOR), Cony-Makhoul, Pascale⁷ (AUTHOR), Coiteux, Valérie⁸ (AUTHOR), Sutton, Laurent⁹ (AUTHOR), Abarah, Wajed¹⁰ (AUTHOR), Pouaty, Camille¹¹ (AUTHOR), Pignon, Jean-Michel¹² (AUTHOR), Choufi, Bachra¹³ (AUTHOR), Visanica, Sorin¹⁴ (AUTHOR), Deau, Bénédicte¹⁵ (AUTHOR), Morisset, Laure¹⁶ (AUTHOR), Cayssials, Emilie¹⁷ (AUTHOR), Molimard, Mathieu¹⁸ (AUTHOR), Bouchet, Stéphane¹⁸ (AUTHOR), Mahon, François-Xavier¹⁹ (AUTHOR)

المصدر: Pharmaceutics. Aug2022, Vol. 14 Issue 8, p1676-1676. 12p.

مصطلحات موضوعية: *NILOTINIB, *CHRONIC myeloid leukemia, *IMATINIB, *DRUG monitoring, *DRUG efficacy

المؤلفون: Goutelle, Sylvain, Guidi, Monia, Gotta, Verena, Csajka, Chantal, Buclin, Thierry, Widmer, Nicolas

المصدر: Pharmaceutics; Apr2023, Vol. 15 Issue 4, p1081, 17p

مصطلحات موضوعية: NILOTINIB, IMATINIB, INDIVIDUALIZED medicine, CHRONIC myeloid leukemia, GASTROINTESTINAL stromal tumors, SIMULATED patients

المؤلفون: Bruzzoni-Giovanelli, Heriberto, Zouali, Habib, Sahbatou, Mourad, Maneglier, Benjamin, Cayuela, Jean-Michel, Rebollo, Angelita, Marin, Gustavo H, Geromin, Daniela, Tomczak, Carole, Alberdi, Antonio, Deleuze, Jean-Francois, Rousselot, Philippe

المصدر: Pharmaceutics ; ISSN:1999-4923 ; Volume:16 ; Issue:6

مصطلحات موضوعية: CML, SNP, chronic myeloid leukemia, exome, imatinib, pharmacogenetics, plasma concentration, polymorphism

العلاقة: https://doi.org/10.3390/pharmaceutics16060834Test; https://pubmed.ncbi.nlm.nih.gov/38931954Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11207966Test/

الإتاحة: https://doi.org/10.3390/pharmaceutics16060834Test
https://pubmed.ncbi.nlm.nih.gov/38931954Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11207966Test/